Table 7.
Pathology characteristics | Number of samples | Positive (%) | Negative (%) | P value | |
---|---|---|---|---|---|
Neoadjuvant chemotherapy | Yes | 40 | 35(87.50%) | 5(12.50%) | <0.010* |
No | 32 | 16(50.00%) | 16(50.00%) | ||
Differentiation | Low differentiation | 12 | 10(83.33%) | 2(16.67%) | 0.103 |
High differentiation | 40 | 23(57.50%) | 17(42.5%) | ||
Pathological stage | I-IIa | 61 | 36(59.02%) | 25(40.98%) | 0.034* |
IIb-IV | 20 | 17(85.00%) | 3(15.00%) | ||
Lymph node metastasis | Yes | 18 | 16(88.89%) | 2(11.11%) | 0.017* |
No | 60 | 35(58.33%) | 25(41.67%) | ||
Vascular invasion | Yes | 13 | 12(92.31%) | 1(7.69%) | <0.010* |
No | 55 | 29(52.73%) | 26(47.27%) |
* represents P<0.05.